Harry Anslinger: The Father of Cannabis Prohibition (1937)

On April 23, 2026, Acting Attorney General Todd Blanche signed an order moving state-licensed medical marijuana from Schedule I to Schedule III of the Controlled Substances Act. It was the most significant federal shift in cannabis policy since 1970 — and the beginning of the end of a prohibition framework that traces its roots not to science, not to public health data, not to democratic consensus, but to the ambitions of a single federal bureaucrat working nearly nine decades ago.

His name was Harry Jacob Anslinger, and the story of how he turned a commonly used plant medicine into America's most vilified substance is one of the most consequential — and least understood — chapters in American history.

The Man Who Needed an Enemy

Harry Anslinger didn't start out caring about marijuana. Born in 1892 in Altoona, Pennsylvania, to Swiss immigrant parents, he built his early career in law enforcement and diplomacy, working for the War Department and the Treasury Department during Prohibition. In 1930, at age 38, he was appointed the first commissioner of the newly created Federal Bureau of Narcotics (FBN) — a position he would hold for an extraordinary 32 years.

The timing was terrible. Alcohol Prohibition was crumbling — the 21st Amendment would repeal it in 1933 — and the FBN was a small agency with a small budget and, increasingly, a shrinking mission. Anslinger needed a new enemy to justify his bureau's existence, and he found one in a plant that most Americans had never heard of by its Spanish name: marihuana.

This was the key to Anslinger's strategy. Cannabis had been widely used in American medicine throughout the 19th century. It appeared in over-the-counter tinctures, was prescribed by physicians for pain, insomnia, and nausea, and was listed in the United States Pharmacopeia. Most Americans who had encountered cannabis knew it by its botanical or pharmaceutical names. The word "marihuana" — spelled with an 'h' rather than a 'j' in Anslinger's deliberate formulation — was unfamiliar, foreign-sounding, and easy to associate with Mexican immigrants and Black jazz musicians.

Anslinger exploited this linguistic disconnection ruthlessly.

The Reefer Madness Campaign

Between 1930 and 1937, Anslinger waged what would now be recognized as a disinformation campaign of remarkable sophistication. He collected a file he called the "Gore File" — a collection of violent crimes that he attributed, without credible evidence, to marijuana use. He fed stories to sympathetic newspapers, particularly the Hearst chain, which had its own reasons for demonizing hemp (William Randolph Hearst had significant investments in timber and paper that competed with hemp-based alternatives).

The claims were extraordinary. Anslinger told Congress and the press that marijuana caused insanity, violence, and moral depravity. He testified that it led to interracial relationships — framed as a threat in the deeply segregated America of the 1930s. He claimed that a single marijuana cigarette could turn an otherwise law-abiding citizen into a murderer.

The racial dimension was not subtle. Anslinger publicly stated that "reefer makes darkies think they're as good as white men" and that marijuana's "effect on the degenerate races" was particularly dangerous. He specifically targeted jazz culture, arguing that marijuana was responsible for the music's "satanic" rhythms and that Black musicians were using the drug to seduce white women.

These weren't fringe claims from a marginal figure. This was the head of a federal law enforcement agency, testifying before Congress, shaping national policy, and feeding narratives to the most widely read newspapers in the country.

The Tax Act of 1937

The Marihuana Tax Act of 1937 was Anslinger's legislative masterpiece. Rather than an outright ban — which would have required a constitutional amendment, as alcohol prohibition had — the Act imposed a prohibitively expensive tax and regulatory burden on anyone who dealt in cannabis. Failure to comply with the tax provisions carried criminal penalties, effectively criminalizing possession and sale without technically banning the substance.

The hearings were rushed and one-sided. Anslinger testified extensively, presenting his Gore File anecdotes as evidence. The American Medical Association's legislative counsel, Dr. William C. Woodward, objected strenuously, arguing that the proposed law would impede medical research and that Anslinger's claims about marijuana's dangers were unsupported by scientific evidence. His testimony was largely ignored; one committee member reportedly responded, "If you want to advise us on legislation, you ought to come here with some constructive proposals rather than criticism, rather than trying to throw obstacles in the way of something that the Federal Government is trying to do."

The bill passed with minimal debate. Most members of Congress who voted for it likely didn't realize that "marihuana" was the same plant their constituents knew as cannabis — the medicine in their pharmacies and the hemp in their farmers' fields.

The Escalation

The 1937 Act was just the beginning. Over the next three decades, Anslinger systematically escalated the war on cannabis.

The Boggs Act of 1951 introduced mandatory minimum sentences for drug offenses, including marijuana possession. A first offense carried a minimum of two years in prison. The Narcotics Control Act of 1956 increased penalties further — a first possession offense could now draw up to ten years.

Anslinger also used his position to suppress dissent. When the La Guardia Committee — a panel of scientists and physicians commissioned by New York City Mayor Fiorello La Guardia — published a 1944 report concluding that marijuana was not the dangerous drug Anslinger claimed, he launched a campaign to discredit the findings and threatened to arrest any doctor who dared conduct further cannabis research.

By the time Anslinger retired in 1962, the framework he built was deeply embedded in American law, American culture, and American institutions. The 1970 Controlled Substances Act — which placed marijuana in Schedule I alongside heroin, classifying it as having no accepted medical use and a high potential for abuse — was the natural continuation of the prohibition architecture Anslinger had constructed.

The Human Cost

The numbers tell a devastating story. Since the Controlled Substances Act took effect, more than 29 million Americans have been arrested for marijuana offenses. Black Americans have been arrested for marijuana possession at roughly 3.7 times the rate of white Americans, despite comparable usage rates across racial groups. Hundreds of thousands of people have served prison time for cannabis-related offenses, losing jobs, housing, voting rights, and years of their lives.

The economic toll extends beyond the justice system. Decades of prohibition prevented legitimate research into cannabis's medical applications, delayed treatment options for patients with chronic pain, epilepsy, PTSD, and other conditions, and pushed an enormous market underground — enriching criminal organizations rather than legitimate businesses and tax coffers.

Communities that bore the brunt of enforcement — predominantly Black and Latino neighborhoods — suffered compounding harms: over-policing, family separation, economic destabilization, and the intergenerational trauma of mass incarceration. The social equity programs now being implemented in legal cannabis states are, in essence, attempts to repair damage that traces directly back to policies Anslinger set in motion.

The Irony of 2026

Standing in April 2026, the irony is almost too neat. The DOJ's Schedule III order explicitly acknowledges that marijuana has accepted medical use — the exact opposite of what Anslinger spent his career claiming. The rescheduling was driven not by activism or cultural pressure alone, but by the same kind of scientific and medical evidence that Anslinger spent decades suppressing.

The 3,500-patient study showing 84.5% prescription medication reductions among medical cannabis users. The CU Boulder research demonstrating CBD's neuroprotective properties. The FDA-approved clinical trials for cannabis-based PTSD treatments. The CBN sleep studies outperforming melatonin. All of this research was delayed — by decades — because of a prohibition framework built on racism, bureaucratic self-interest, and deliberate misinformation.

Anslinger died in 1975, five years after the Controlled Substances Act cemented his legacy into federal law. He never faced accountability for the lives destroyed by his campaigns, never confronted the scientific evidence that contradicted his claims, and never acknowledged the racial animus that fueled his crusade.

Why This History Matters Now

Understanding Anslinger's role isn't just an academic exercise. It's essential context for the policy debates happening right now. When opponents of cannabis reform argue that marijuana is too dangerous to legalize, they're drawing on a narrative framework that Anslinger constructed from whole cloth in the 1930s. When federal agencies insist on maintaining restrictions despite overwhelming evidence of safety, they're operating within an institutional culture that Anslinger shaped.

And when social equity advocates argue that cannabis legalization must include restorative justice for communities harmed by prohibition, they're asking the country to reckon with the specific, documented, deliberate origins of the policies that caused that harm.

The Marihuana Tax Act of 1937 is 89 years old this year. Its direct descendant, Schedule I classification, is finally being dismantled. But the full reckoning with Anslinger's legacy — and the millions of lives it affected — is just beginning.

The giant spliff scroll headed to Congress may get the headlines. The real story is the 89-year-old policy framework that's finally, slowly, starting to unravel — and the man who built it from nothing but ambition, prejudice, and a talent for propaganda.

Find verified shops near you in Budpedia's cannabis dispensary directory.